DataMeds AI to present at telehealth summit

DataMeds AI will send Interim Co-CEO Gerald Commissiong to Las Vegas on Sept. 28 to discuss patient ownership of health data and the company’s push to expand telehealth and pharmaceutical access. The appearance comes as the company promotes its Health Lives Here campaign and mobile app with NFL Alumni Health.

Why it matters: - DataMeds AI is using the summit to spotlight its pitch that patients should be able to own and control their health data. - The company is tying that message to its broader plan to expand access to telehealth and pharmaceutical services. - The presentation comes as healthcare groups continue to look for ways to improve access, reduce friction and lower costs in virtual care.

What happened: - DataMeds AI said Interim Co-CEO Gerald Commissiong will present “What Patients Really Want” at the 2026 National Telehealth and Virtual Care Summit in Las Vegas on Monday, Sept. 28, 2026, at 9:15 a.m. PT. - Commissiong will discuss patient demand for ownership of individual health data. - The company will also highlight its “Health Lives Here” campaign and mobile healthcare application developed with NFL Alumni Health. - DataMeds AI is listed as a B2i Digital Featured Company. - The company directs readers to its in-depth profile. - The company directs readers to its website.

The details: - DataMeds AI describes itself as a healthcare company that combines Health IT and physical infrastructure with its EinsteinRx AI platform and PharmacyChain smart contracts platform. - Commissiong said the company wants to help patients use newer technologies to access appropriate treatments and improve care in communities with limited access. - Commissiong said the presentation will outline how patient ownership of data could improve patient care and reduce provider frustrations with data access. - The summit will focus on strategies to improve healthcare delivery, patient care and outcomes, accessibility, data analytics and cost reduction. - The event will bring together healthcare leaders, clinicians, technology experts and policymakers. - DataMeds AI says its headquarters are in Tampa, Fla. - The company says its Corexa Health subsidiary provides pharmacy dispensing and pharmacy-related services, including distribution of products developed by Tollo Health, LLC.

Between the lines: - The summit appearance gives DataMeds AI a public stage to frame data ownership as both a patient-rights issue and a workflow issue for providers. - The company is also positioning telehealth, pharmacy services, AI and blockchain-enabled tools as parts of one connected healthcare system. - The forward-looking language in the release signals that management is still pitching expansion rather than reporting completed operating results.

What's next: - Commissiong is scheduled to deliver the presentation on Sept. 28. - DataMeds AI says it is continuing to expand its Health Lives Here app and related digital health platforms. - The company also points to planned growth in telemedicine and diagnostic laboratory services in its forward-looking statements. - DataMeds AI says it is pursuing a proposed transaction with DataVault AI Inc., Scilex Holding Company, EOS Holdings and HealthBridge Advisors, subject to required approvals and closing conditions.

The bottom line: - DataMeds AI is using the Las Vegas summit to press a broader message: patient-controlled data can be a lever for better access, smoother care delivery and new digital health services.